Acuta Sells Ocular Therapeutix Stake
Acuta Capital reduces its holdings in Ocular Therapeutix by 56% in Q1, potentially impacting the stock's performance. This sale may affect investor sentiment.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.